Table 3.
Mean weekly increase in weight (kg) and percent of treatment goal weight (TGW) for comparison and medication groups
| Comparison | Medication | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Week range | n | Weight M (SD) | % of TGW M (SD) | n | Weight M (SD) | % of TGW M (SD) |
| Baseline to week 1 | 10 | 1.07 (0.67) | 1.84 (1.11) | 13 | 1.24 (1.16) | 2.24 (1.99) |
| Week 1 to week 2 | 10 | 0.77 (0.63) | 1.39 (1.15) | 13 | 1.21 (0.93) | 2.12 (1.43) |
| Week 2 to week 3 | 10 | 1.08 (0.65) | 1.90 (1.17) | 12 | 1.40 (1.25) | 2.66 (2.44) |
| Week 3 to week 4 | 10 | 0.81 (0.78) | 1.45 (1.37) | 11 | 1.55 (0.93) | 2.70 (1.19) |
| Week 4 to week 6* | 7 | 1.51 (1.27) | 2.67 (2.23) | 9 | 2.72 (0.86) | 5.07 (2.12) |
| Week 6 to week 8* | 6 | 1.27 (0.93) | 2.26 (1.75) | 9 | 1.98 (1.05) | 3.50 (1.61) |
| Week 8 to week 10* | 5 | 1.04 (1.41) | 1.71 (2.43) | 5 | 2.12 (0.68) | 3.64 (1.36) |
| Week 10 to week 12* | 6 | .33 (0.23) | 0.60 (0.40) | 3 | 0.87 (1.61) | 1.59 (2.91) |
*
2-week interval
TGW = Treatment Goal Weight
Note: Values for medication group participants are only those values while they were taking olanzapine (hence decrease in sample size as study progresses). Total sample size is 24, but because some values are missing, weekly n does not add up to 24.